Collegium Pharmaceutical Inc (STU:354)
€ 34.4 -0.2 (-0.58%) Market Cap: 1.13 Bil Enterprise Value: 1.39 Bil PE Ratio: 14.97 PB Ratio: 5.78 GF Score: 72/100

Q4 2019 Collegium Pharmaceutical Inc Earnings Call Transcript

Feb 27, 2020 / 09:30PM GMT
Release Date Price: €19.8 (-5.71%)
Operator

Good day, ladies and gentlemen, and thank you for standing by, and welcome to the Fourth Quarter 2019 Collegium Pharmaceutical Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I will now hand the conference over to your first speaker today, Alex Dasalla, Head of Investor Relations.

Alex Dasalla
Collegium Pharmaceutical, Inc. - Head of IR

Welcome to Collegium Pharmaceutical's Fourth Quarter 2019 Earnings Conference Call. This is Alex Dasalla, Head of Investor Relations for Collegium. I am joined today by Joe Ciaffoni, our Chief Executive Officer; Paul Brannelly, our Chief Financial Officer; and Scott Dreyer, our Chief Commercial Officer.

Before we begin today's call, we want to remind participants that none of the information presented today is intended to be promotional, and that any forward-looking statements made today are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995.

You are cautioned that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot